Application 089307
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROTAMINE SULFATE | PROTAMINE SULFATE | Injectable; Injection | 50MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | c76876da-b9a8-45d0-9278-7df3288d3a06 | 2025-04-29 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | e1964129-33f4-4e4e-86e3-8e6a4e65bd83 | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | 7a31fc4c-579f-45cc-9559-39cfad9a57b3 | 2024-03-18 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| PROTAMINE SULFATE | PROTAMINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 94d4f57f-940e-c0a8-e053-2a95a90ae3af | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | PROTAMINE SULFATE PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | 8df0a819-9e1a-44ce-97a6-3ea82c867d44 | 2024-01-18 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.